Aster DM Healthcare Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aster DM Healthcare Limited generated cash of $1,578,100,000, which is less than the previous year. Cash used in financing activities reached the amount of $10,528,300,000 last year. Net change in cash is therefore $3,323,900,000.
Cash Flow
| 2016 | 2.02B | -7.85B | 5.77B |
|---|---|---|---|
| 2018 | 5.37B | -5.22B | 456.8M |
| 2020 | 12.23B | -6.67B | -6.74B |
| 2021 | 15.69B | -3.30B | -11.16B |
| 2023 | 18.33B | -9.71B | -8.17B |
| 2024 | 1.57B | -8.84B | 10.52B |
ASTERDM.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 3.65B | 2.99B | 1.14B | 2.24B | 1.31B | 2.47B |
Operating activities | ||||||
Net income | 1.29B | 5.35B | 2.05B | 3.49B | 1.75B | 384.25M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.19B | 7.80B | 6.17B | 5.85B | 2.97B | 2.43B |
Stock-based compensation expense | 73.6M | 6.7M | 24.9M | 11.9M | 43.44M | 87.04M |
| Deferred income tax benefit | 73.6M | 6.7M | 24.9M | 11.9M | 43.44M | 87.04M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -2.21B | -3.18B | 359.5M | -3.26B | -1.25B | -7.82B |
Inventories | -3.03B | -1.92B | 945.7M | -1.48B | -999.08M | -823.46M |
Accounts payable | 5.52B | 7.77B | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 1.57B | 18.33B | 15.69B | 12.23B | 5.37B | 2.02B |
Investing activities | ||||||
Purchases Of Investments | 0 | -46.1M | -125.3M | -91.7M | -653.3M | -483.88M |
Investments In Property Plant And Equipment | -7.96B | -8.48B | -4.23B | -5.30B | -5.19B | -7.60B |
Acquisitions Net | 0 | -1.30B | 654.1M | -2.33B | -79.66M | -17.69B |
Cash generated by investing activities | -8.84B | -9.71B | -3.30B | -6.67B | -5.22B | -7.85B |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 7.9M | 10.4M | 6.80B | 792.61M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -1.2B | 0 | 0 |
Repayments of term debt | 18.10B | -6.89B | -5.55B | -1.26B | -4.17B | 7.81B |
Cash used in financing activities | 10.52B | -8.17B | -11.16B | -6.74B | 456.8M | 5.77B |
Net Change In Cash | 3.32B | 657.4M | 1.19B | -1.09B | 606.29M | 50.07M |
Cash at end of period | 6.97B | 3.65B | 2.34B | 1.14B | 1.91B | 2.52B |
| Data source | Data source | Data source | Data source | Data source | Data source |